Cargando…
Silymarin in the management of liver enzyme activity in steatohepatitis: a case report
Metabolic-associated fatty liver disease (MAFLD) is the main condition of altered liver enzymes worldwide. With a constant increase in liver hospitalizations, MAFLD is the second cause of cirrhosis and soon will be the first cause of liver transplantation. Early recognition of MAFLD and a personaliz...
Autor principal: | Torre, Aldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108663/ https://www.ncbi.nlm.nih.gov/pubmed/37077767 http://dx.doi.org/10.7573/dic.2023-1-5 |
Ejemplares similares
-
Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report
por: Hashem, Ahmed
Publicado: (2023) -
Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
por: Lee, Yeong Yeh, et al.
Publicado: (2023) -
Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
por: Chantarojanasiri, Tanyaporn
Publicado: (2023) -
Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
por: Lee, Yeong Yeh, et al.
Publicado: (2023) -
Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review
por: Calderon Martinez, Ernesto, et al.
Publicado: (2023)